RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30070972http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30070972http://www.w3.org/2000/01/rdf-schema#comment"Since early diagnosis is very important for treating CRC, we decided to detect peripheral serum canopy fibroblast growth factor signaling regulator 2 (CNPY2) isoform 2 to verify its diagnostic value for CRC patients. Serum samples were collected from 430 CRC patients and 201 healthy controls. Enzyme-linked immunosorbent assay (ELISA) detection kits for CNPY2 isoform 2 were generated and then applied to measure serum CNPY2 isoform 2 concentrations. Serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were also measured. The median serum CNPY2 isoform 2 concentrations in all CRC patients were significantly higher than those in the healthy control group (all P<0.001). Those with stage I CRC presented the highest area under the receiver operating characteristic curve (AUC) for CNPY2 isoform 2 [0.707, 95% confidence interval (CI): 0.649-0.765, P<0.001]. The diagnostic efficiency of the combination of CNPY2 isoform 2, CEA and CA19-9 was significantly higher than that of each biomarker detected separately (all P<0.0167). Serum CNPY2 isoform 2 may be a valuable biomarker for the early detection of CRC and presents an improvement in the diagnostic efficiency by combination of CEA and CA19-9."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.org/dc/terms/identifier"doi:10.18632/aging.101512"xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Fang Y."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Deng Y."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Guo J."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Li C."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Lu Z."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Peng J."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Zhang R."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Zhang L."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Zhou Y."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Zhao Y."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Wan D."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Ou Q."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/author"Pan Z."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/name"Aging (Albany NY)"xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/pages"1921-1931"xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/title"Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer."xsd:string
http://purl.uniprot.org/citations/30070972http://purl.uniprot.org/core/volume"10"xsd:string
http://purl.uniprot.org/citations/30070972http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30070972
http://purl.uniprot.org/citations/30070972http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30070972
http://purl.uniprot.org/uniprot/#_A0A024R0K5-mappedCitation-30070972http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30070972
http://purl.uniprot.org/uniprot/#_Q13984-mappedCitation-30070972http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30070972